IQVIA Holdings Inc. (IQV)
Pre-market:
| Previous close | 238.62 |
| Open | 238.30 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 900 |
| Day's range | 237.70 - 244.27 |
| 52-week range | 167.42 - 261.73 |
| Volume | |
| Avg. volume | 955,048 |
| Market cap | 43.836B |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | 32.99 |
| EPS (TTM) | 7.30 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 276.35 |
Insider Monkey10 Stocks Hedge Funds Are Talking About
Stock markets often overreact to hype causing fluctuations in stock prices and overvaluation. In recent quarters, there is immense interest in tech giants contributed by the developments in generative AI. However, before investing, it is crucial to analyze a company’s ability to withstand competitive forces and assess its sustainability. At Insider Monkey, we focus on […]
Simply Wall St.Insiders At IQVIA Holdings Sold US$10m In Stock, Alluding To Potential Weakness
The fact that multiple IQVIA Holdings Inc. ( NYSE:IQV ) insiders offloaded a considerable amount of shares over the...
- Business Wire
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
RESEARCH TRIANGLE PARK, N.C., April 23, 2024--IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.
